Aragen Life Sciences
-
Strengthens discovery-to-development integrated platform with addition of GLP certified safety assessment capabilities
15 December 2021: Aragen Life Sciences, a global research, development, and manufacturing solutions provider (CRO/CDMO), announced that it has signed…
Read More » - Business Wire
Aragen Announces Partnership with Skyhawk Therapeutics, Aimed at Developing Novel Small Molecule Therapeutics that Correct RNA Expression
HYDERABAD, India–(BUSINESS WIRE)–#Aragen–Aragen Life Sciences (formerly, GVK BIO), a leading Contract Research and Development Organization (CRDO), headquartered out of Hyderabad,…
Read More » - Business Wire
Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim
HYDERABAD, India–(BUSINESS WIRE)–#Aragen–Aragen Life Sciences (formerly GVK BIO), a leading Contract Research and Development Organization, headquartered out of Hyderabad, India,…
Read More » - Business
Aragen (Formerly GVK BIO) To Partner With Global Biopharma With a Renewed Brand Promise
Hyderabad, Telangana, India: Aragen Life Sciences (Aragen), formerly known as GVK Biosciences and a leading contract research, development and manufacturing…
Read More » - Business
Goldman Sachs Invests in Aragen Life Sciences
Hyderabad, India: Aragen Life Sciences (“Aragen”), formerly known as GVK Biosciences and a leading contract research organization (CRO), announced today…
Read More »